Considerations for an

cardiomyocyte contractility inotropic state myocardium stem cells

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2019
Historique:
received: 19 03 2019
accepted: 15 07 2019
entrez: 27 8 2019
pubmed: 27 8 2019
medline: 27 8 2019
Statut: epublish

Résumé

Drug-induced effects on cardiac contractility can be assessed through the measurement of the maximal rate of pressure increase in the left ventricle (LVdP/dt

Identifiants

DOI: 10.3389/fphar.2019.00884 PMID: 31447679 PMC: PMC6697071
pubmed: 31447679
doi: 10.3389/fphar.2019.00884
pmc: PMC6697071
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

884

Références

Am J Physiol Heart Circ Physiol. 2002 Jan;282(1):H131-7
pubmed: 11748056
Am J Emerg Med. 2002 Oct;20(6):497-501
pubmed: 12369019
Cardiovasc Res. 1977 Jan;11(1):17-25
pubmed: 12867
J Biol Chem. 1992 Jun 25;267(18):12545-51
pubmed: 1320000
J Pharmacol Exp Ther. 1961 Dec;134:373-89
pubmed: 13870003
Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1435-45
pubmed: 15165985
Eur J Pharmacol. 2004 Oct 1;500(1-3):73-86
pubmed: 15464022
Ann N Y Acad Sci. 2006 Oct;1080:248-67
pubmed: 17132788
Toxicology. 2008 Mar 20;245(3):206-18
pubmed: 18249481
Int J Biochem Cell Biol. 2008;40(10):2023-39
pubmed: 18407781
J Exp Biol. 2008 Jul;211(Pt 13):2005-13
pubmed: 18552289
Circulation. 2008 Sep 2;118(10):1047-56
pubmed: 18765387
J Cell Sci. 2009 Jun 15;122(Pt 12):2119-26
pubmed: 19470580
Toxicol In Vitro. 2010 Apr;24(3):960-72
pubmed: 20064605
Clin Transl Sci. 2009 Feb;2(1):15-25
pubmed: 20376335
Pharmacol Ther. 2010 Oct;128(1):191-227
pubmed: 20438756
Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):114-20
pubmed: 20728698
Cancer Treat Rev. 2011 Jun;37(4):300-11
pubmed: 21126826
Toxicol Sci. 2011 Mar;120(1):14-32
pubmed: 21177772
Methods Mol Biol. 2011;740:1-6
pubmed: 21468961
Circ Res. 2011 Jun 24;109(1):47-59
pubmed: 21597009
Cell Physiol Biochem. 2011;27(5):453-62
pubmed: 21691062
Toxicol Sci. 2011 Sep;123(1):281-9
pubmed: 21693436
J Pharmacol Toxicol Methods. 2012 May-Jun;65(3):126-35
pubmed: 22521339
PLoS One. 2012;7(5):e37559
pubmed: 22624048
Am J Physiol Heart Circ Physiol. 2012 Jul 15;303(2):H156-67
pubmed: 22636675
Toxicol Sci. 2012 Nov;130(1):117-31
pubmed: 22843568
J Pharmacol Toxicol Methods. 2012 Nov-Dec;66(3):246-56
pubmed: 22926323
J Biomol Screen. 2013 Jan;18(1):39-53
pubmed: 22972846
Am J Physiol Heart Circ Physiol. 2014 May;306(9):H1353-63
pubmed: 24585781
Eur J Clin Invest. 1988 Dec;18(6):600-6
pubmed: 2465159
Cardiovasc Res. 2014 Sep 1;103(4):554-63
pubmed: 24947416
Prog Biophys Mol Biol. 2014 Aug;115(2-3):103-14
pubmed: 24976617
J Mol Cell Cardiol. 2014 Dec;77:178-91
pubmed: 25257913
Tissue Eng Part C Methods. 2015 May;21(5):467-79
pubmed: 25333967
J Lab Autom. 2015 Apr;20(2):175-88
pubmed: 25532527
Toxicol Sci. 2015 Apr;144(2):227-37
pubmed: 25538221
J Transl Med. 2015 Jan 16;13:1
pubmed: 25591711
J Mol Cell Cardiol. 2015 Apr;81:81-93
pubmed: 25644533
Phys Rev Lett. 2015 Feb 13;114(6):062002
pubmed: 25723208
Toxicol Sci. 2015 Jun;145(2):396-406
pubmed: 25820236
J Pharmacol Toxicol Methods. 2015 Sep-Oct;75:70-90
pubmed: 25843226
World J Cardiol. 2015 Apr 26;7(4):204-14
pubmed: 25914789
Biomaterials. 2015 Aug;60:82-91
pubmed: 25985155
J Pharmacol Toxicol Methods. 2015 Sep-Oct;75:62-9
pubmed: 26026903
Circ Res. 2015 Jun 19;117(1):80-8
pubmed: 26089365
J Biomol Screen. 2016 Jan;21(1):1-11
pubmed: 26170255
Curr Protoc Chem Biol. 2015 Sep 01;7(3):141-185
pubmed: 26331525
Toxicol Sci. 2015 Dec;148(2):503-16
pubmed: 26358003
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1453-67
pubmed: 26386112
J Vis Exp. 2015 Sep 17;(103):null
pubmed: 26436250
Front Cell Dev Biol. 2015 Sep 29;3:59
pubmed: 26484342
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1728-48
pubmed: 26524115
Stem Cell Reports. 2015 Dec 8;5(6):1226-1238
pubmed: 26626178
FASEB J. 2016 Apr;30(4):1464-79
pubmed: 26675706
PLoS One. 2016 Jan 25;11(1):e0146415
pubmed: 26808388
PLoS One. 2016 Feb 03;11(2):e0145937
pubmed: 26840448
CA Cancer J Clin. 2016 Jul;66(4):309-25
pubmed: 26919165
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1717-27
pubmed: 26952934
Cell Physiol Biochem. 2016;38(3):1182-98
pubmed: 26983082
J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:223-32
pubmed: 27084108
Sci Rep. 2016 May 04;6:25333
pubmed: 27142468
J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:240-50
pubmed: 27184445
Stem Cell Reports. 2016 Jul 12;7(1):29-42
pubmed: 27211213
PLoS One. 2016 Jun 09;11(6):e0156862
pubmed: 27281038
Circulation. 2016 Nov 15;134(20):1557-1567
pubmed: 27737958
Br J Pharmacol. 1989 Aug;97(4):1199-208
pubmed: 2790382
Toxicol Sci. 2017 Feb;155(2):444-457
pubmed: 28069985
Circulation. 2017 May 9;135(19):1832-1847
pubmed: 28167635
Circ Res. 2017 May 12;120(10):1572-1583
pubmed: 28400398
Toxicol Sci. 2017 Jul 1;158(1):164-175
pubmed: 28453742
Circ J. 2017 Sep 25;81(10):1395-1402
pubmed: 28539561
Tissue Eng Part C Methods. 2017 Aug;23(8):445-454
pubmed: 28562232
Circ Res. 2017 Jul 7;121(2):181-195
pubmed: 28684623
Sci Rep. 2017 Jul 14;7(1):5464
pubmed: 28710467
Oxid Med Cell Longev. 2017;2017:3920195
pubmed: 28751931
Assay Drug Dev Technol. 2017 Aug/Sep;15(6):280-296
pubmed: 28837356
Circ Res. 2017 Sep 15;121(7):874-891
pubmed: 28912188
Nucleic Acids Res. 2017 Sep 19;45(16):e148
pubmed: 28934479
Clin Pharmacol Ther. 2018 Jan;103(1):54-66
pubmed: 28986934
Stem Cell Reports. 2017 Nov 14;9(5):1560-1572
pubmed: 29033305
Circ Res. 2018 Feb 2;122(3):e5-e16
pubmed: 29282212
Am J Med. 1986 Oct 31;81(4C):40-5
pubmed: 2946223
J Cardiovasc Transl Res. 2018 Oct;11(5):375-392
pubmed: 29557052
Cardiovasc Eng Technol. 2018 Sep;9(3):529-538
pubmed: 29948837
Basic Res Cardiol. 2019 Feb 14;114(2):12
pubmed: 30767143
APL Bioeng. 2018 Mar 20;2(2):026102
pubmed: 31069299
J Am Coll Cardiol. 1988 Feb;11(2):438-45
pubmed: 3276755
Circ Res. 1973 Mar;32(3):314-22
pubmed: 4691336
Circulation. 1971 Jul;44(1):47-58
pubmed: 5561416
Comp Biochem Physiol Physiol. 1994 Sep;109(1):1-22
pubmed: 8076447
Circulation. 1993 Nov;88(5 Pt 1):2267-76
pubmed: 8222121
Basic Res Cardiol. 1996 Jan-Feb;91(1):86-93
pubmed: 8660266
Eur J Pharmacol. 1995 Dec 27;294(1):17-27
pubmed: 8788412
Circulation. 1997 May 6;95(9):2312-7
pubmed: 9142010
Biull Eksp Biol Med. 1997 Apr;123(4):414-6
pubmed: 9190182
Magn Reson Med. 1998 Apr;39(4):507-13
pubmed: 9543411

Auteurs

Brian D Guth (BD)

Department of Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany.
PreClinical Drug Development Platform (PCDDP), North-West University, Potchefstroom, South Africa.

Michael Engwall (M)

Safety Pharmacology and Animal Research Center, Amgen Research, Thousand Oaks, CA, United States.

Sandy Eldridge (S)

Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

C Michael Foley (CM)

Department of Integrative Pharmacology, Integrated Sciences and Technology, AbbVie, North Chicago, IL, United States.

Liang Guo (L)

Laboratory of Investigative Toxicology, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, United States.

Gary Gintant (G)

Department of Integrative Pharmacology, Integrated Sciences and Technology, AbbVie, North Chicago, IL, United States.

John Koerner (J)

Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.

Stanley T Parish (ST)

Health and Environmental Sciences Institute, Washington, DC, United States.

Jennifer B Pierson (JB)

Health and Environmental Sciences Institute, Washington, DC, United States.

Alexandre J S Ribeiro (AJS)

Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translation Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.

Tanja Zabka (T)

Department of Safety Assessment, Genentech, South San Francisco, CA, United States.

Khuram W Chaudhary (KW)

Global Safety Pharmacology, GlaxoSmithKline plc, Collegeville, PA, United States.

Yasunari Kanda (Y)

Division of Pharmacology, National Institute of Health Sciences, Kanagawa, Japan.

Brian Berridge (B)

National Toxicology Program, National Institute of Environmental Health Sciences, Durham, NC, United States.

Classifications MeSH